SEQing to find hidden medulloblastoma cells.
Journal
Cancer cell
ISSN: 1878-3686
Titre abrégé: Cancer Cell
Pays: United States
ID NLM: 101130617
Informations de publication
Date de publication:
08 11 2021
08 11 2021
Historique:
pubmed:
23
10
2021
medline:
28
12
2021
entrez:
22
10
2021
Statut:
ppublish
Résumé
Minimal residual disease (MRD) assessment has revolutionized the clinical management of pediatric leukemias but has remained challenging to implement in pediatric brain tumors. In this issue of Cancer Cell, Liu et al. describe an approach to measuring MRD in pediatric medulloblastoma through the use of cell-free DNA in cerebrospinal fluid, with important prognostic implications.
Identifiants
pubmed: 34678149
pii: S1535-6108(21)00503-1
doi: 10.1016/j.ccell.2021.09.014
pii:
doi:
Types de publication
Journal Article
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
1452-1454Commentaires et corrections
Type : CommentOn
Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.